about
ACR Appropriateness Criteria Stage I Breast Cancer: Initial Workup and Surveillance for Local Recurrence and Distant Metastases in Asymptomatic Women.Intrafractional target motions and uncertainties of treatment setup reference systems in accelerated partial breast irradiation.Utilization of breast conserving therapy in stages 0, I, and II breast cancer patients in New Jersey: an American College of Surgeons National Cancer Data Base (NCDB) analysis.Ionizing radiation sensitizes breast cancer cells to Bcl-2 inhibitor, ABT-737, through regulating Mcl-1Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) as a prognostic marker for local control in T1-2 N0 breast cancer treated with breast-conserving surgery and radiation therapy (BCS + RT).Treatment techniques to reduce cardiac irradiation for breast cancer patients treated with breast-conserving surgery and radiation therapy: a reviewOptimization of heart block in the left-sided whole breast radiation treatmentsTagged MRI based cardiac motion modeling and toxicity evaluation in breast cancer radiotherapy.Radiation-induced heart disease: pathologic abnormalities and putative mechanismsPatterns of intrafractional motion and uncertainties of treatment setup reference systems in accelerated partial breast irradiation for right- and left-sided breast cancer.Current application and research directions for partial-breast irradiation.Predictive parameters for selection of electronic tissue compensation radiotherapy in early-stage breast cancer patients after breast-conserving surgery.Clinicopathologic presentation of Asian-Indian American (AIA) women with stage 0, I & II breast cancer.Evaluation of single nucleotide polymorphisms (SNPs) in the p53 binding protein 1 (TP53BP1) gene in breast cancer patients treated with breast-conserving surgery and whole-breast irradiation (BCS + RT).Evaluation of Diabetic Patients with Breast Cancer Treated with Metformin during Adjuvant Radiotherapy.Three-year outcomes of a once daily fractionation scheme for accelerated partial breast irradiation (APBI) using 3-D conformal radiotherapy (3D-CRT).Effect of travel distance and time to radiotherapy on likelihood of receiving mastectomy.Evaluation of acute locoregional toxicity in patients with breast cancer treated with adjuvant radiotherapy in combination with bevacizumab.Evaluation of vascular endothelial growth factor as a prognostic marker for local relapse in early-stage breast cancer patients treated with breast-conserving therapy.ACR Appropriateness Criteria® conservative surgery and radiation--stage I and II breast carcinoma: expert panel on radiation oncology: breast.ACR appropriateness criteria® locally advanced breast cancer.ACR appropriateness criteria(®) ductal carcinoma in situ.ACR Appropriateness Criteria® local-regional recurrence (LR) and salvage surgery: breast cancer.Lumpectomy closure technique does not affect dosimetry in patients undergoing external-beam-based accelerated partial breast irradiation.ACR Appropriateness Criteria local-regional recurrence (LRR) and salvage surgery-breast cancer.ACR Appropriateness Criteria® Ductal Carcinoma in Situ.Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II Trial.Oncoplastic breast surgery in the setting of breast-conserving therapy: A systematic review.An Emerging Role for Radiation Oncology in Precision Oncology.Comparison of Mammographic Changes Across Three Different Fractionation Schedules for Early-Stage Breast Cancer.Racial Disparities in Hypofractionated Radiotherapy Breast Cancer Clinical Trials.Trends in active surveillance for very low-risk prostate cancer: do guidelines influence modern practice?Evaluation of acute locoregional toxicity in patients with breast cancer treated with adjuvant radiotherapy in combination with pazopanib.Prognostic significance of IGF-1R expression in patients treated with breast-conserving surgery and radiation therapy.Clinicopathologic significance of excision repair cross-complementation 1 expression in patients treated with breast-conserving surgery and radiation therapy.Factors associated with optimal cosmetic results at 36 months in patients treated with accelerated partial breast irradiation (APBI) on the American Society of Breast Surgeons (ASBrS) MammoSite Breast Brachytherapy Registry Trial.Low p53 binding protein 1 (53BP1) expression is associated with increased local recurrence in breast cancer patients treated with breast-conserving surgery and radiotherapy.Object-constrained meshless deformable algorithm for high speed 3D nonrigid registration between CT and CBCT.Tracking the dynamic seroma cavity using fiducial markers in patients treated with accelerated partial breast irradiation using 3D conformal radiotherapy.Has Placement of Surgical Clips in the Lumpectomy Bed Fallen Out of Favor?
P50
Q30275486-F1071FDA-432C-4CDE-AE17-F6DACC4BF983Q33676463-8DE9D146-AFF9-459F-8F7E-F159F7BAD961Q33821893-C905DE5E-FE48-4B42-A81D-A2FE8ADA899DQ33924886-7592198F-E6F9-4F83-AA35-F5EDA6A3F1FEQ33924893-8C9FB046-0697-4501-8790-7008844A549FQ34510494-8B2BD506-F31F-4F8A-AFDA-8F106A6A2747Q34608231-724919EB-089A-455E-8D5F-A3DBE65F04CBQ35042114-D1887DDA-7F06-4353-9ED6-6F7F8754F049Q35094533-31E666DE-1526-4FC1-9813-99114CF101AAQ35118523-1723E0D8-E96E-4BDA-878E-07B01FAA229EQ36808893-B7EB1AF9-6B00-4DAC-90A2-74C2DEB7FFC6Q37362782-F71944C9-70EF-4520-8C6D-7A863D5642DFQ37421785-69730487-801B-490D-9401-3C213DBB7A32Q37421810-CB5BDC05-B560-4718-AE96-412BB0171563Q37422431-F1EB2BC3-1A0F-4B23-B450-A0DBB4C066BEQ37481231-49BA3D72-8856-46BD-AB33-A72D8B53374EQ37715071-19F57113-CC40-4EE3-81B0-2645EF0E8F8DQ37745922-15F17F2D-D168-47B9-8772-B9F9AC210227Q37811165-5F9FC4DA-95EC-4845-9E58-A2AA1B810505Q37905913-CD0D0806-683D-4B43-980F-A488DDFE0528Q37929856-AABB5B8F-75A8-4B2F-950F-777BF3D3DE52Q37959573-50D4D6A1-F2D9-49FA-8BFA-C2EECC7A5A7FQ37995473-06414DE2-08AF-4AE8-81DA-6170515DEF70Q38066349-EC9E6531-534B-46C7-BF1E-499DE2225427Q38202127-AE5470F3-9976-4A38-95D8-CABBE8018C07Q38531784-DAE2ACC2-4C57-4DEF-A6D2-DC6B1A838AF5Q38811255-707FA0DA-0146-4DB0-ABEE-BC8EAB7D0FBAQ39456147-466C8361-6DE8-4B13-978F-B60D55A23CDBQ39761934-1C3AEA4B-62A4-4BAD-A14B-BE3EA909379FQ39872859-BCAFA209-51EC-4FE0-B113-A193C96DAC18Q41005803-77C70776-F367-4B93-90AC-56C525F1C8CFQ42373315-58F9272E-1DA5-4953-9B06-9EF3C0B25D15Q42413228-96D85532-B438-4669-A610-58722F737987Q43816195-12D95270-1396-4A1C-B3AA-89169F8C361AQ43981317-6777A0BA-CC67-4930-B2E0-28A35C1618F0Q44138065-8C4142D2-73A8-4811-9033-9A01BC1A54F7Q44283161-2242DD21-618F-44B9-97DE-AEF890E5EB40Q44492819-94AFCC17-5D03-48F6-845C-9ED14A763FACQ44537684-2A65A394-524A-4E27-847B-B20EDDCD82C2Q46024289-7DA25BEC-931A-4FE5-90AA-90C9498771A6
P50
name
Bruce G Haffty
@ast
Bruce G Haffty
@en
Bruce G Haffty
@nl
type
label
Bruce G Haffty
@ast
Bruce G Haffty
@en
Bruce G Haffty
@nl
prefLabel
Bruce G Haffty
@ast
Bruce G Haffty
@en
Bruce G Haffty
@nl
P214
P21
P214
P31
P3762
P735
P7859
lccn-n98803344